shoreline Call: 843-365-8884
able tool to detect the presence of fentanyl in drug samples and alert users to potential dangers. It's im- portant to note that while a negative test result pro- vides some reassurance, all unprescribed drug use carries inherent risks, underscoring the importance of comprehensive harm reduction practices and in- formed decision-making. Shoreline has forged partnerships with local medical practices to offer clients access to primary healthcare services and evidence-based Medication Assisted Treatment (MAT). MAT has demonstrated effica-
cy in various aspects, including enhancing birth outcomes for pregnant women with substance use disorders, reducing opiate/ opioid misuse and overdose rates, improv- ing treatment retention and satisfaction, and effectively managing withdrawal symptoms to enhance overall well-being. Through the integration of FDA-approved medications like Suboxone and Vivitrol, coupled with counseling and behavioral interventions, Shoreline's MAT services present a holistic approach to addiction treatment, addressing both physical and psychological aspects of recovery. Shoreline Behavioral Health's commitment to supporting harm reduction efforts un- derscores a dedication to preserving lives, advancing community health, and fostering resilience amidst substance-related chal- lenges. By offering essential resources, col- laborating with local stakeholders, and pro- viding evidence-based treatment options, Shoreline aims to empower individuals to navigate their recovery journey with dignity, support, and comprehensive care. Through a multifaceted approach encompassing harm reduction initiatives and medication-assist- ed interventions, Shoreline continues to be a source of hope and healing for those impact- ed by substance use disorders, embodying a steadfast commitment to promoting well- ness and recovery within the community.
| 15
Made with FlippingBook - professional solution for displaying marketing and sales documents online